The aprocitentan market is estimated at USD 42.44 million in 2026, is projected to reach USD 112.31 million by 2036 and is forecast to register a 10.22% CAGR between 2026 and 2036. In 2026, direct sales hold 74.0% within the sales channel segment and powder represents 71.0% of the form category.